Your browser is no longer supported. Please, upgrade your browser.
ChromaDex Corporation
Index- P/E- EPS (ttm)-0.36 Insider Own1.30% Shs Outstand67.99M Perf Week-17.39%
Market Cap430.46M Forward P/E- EPS next Y-0.11 Insider Trans-4.58% Shs Float45.68M Perf Month-20.20%
Income-23.30M PEG- EPS next Q-0.09 Inst Own30.40% Short Float8.22% Perf Quarter-36.74%
Sales62.00M P/S6.94 EPS this Y42.10% Inst Trans-6.70% Short Ratio6.75 Perf Half Y-45.23%
Book/sh0.62 P/B10.19 EPS next Y68.60% ROA-44.20% Target Price- Perf Year39.82%
Cash/sh0.57 P/C11.09 EPS next 5Y- ROE-76.30% 52W Range3.82 - 23.66 Perf YTD31.67%
Dividend- P/FCF- EPS past 5Y-33.40% ROI- 52W High-73.29% Beta1.64
Dividend %- Quick Ratio2.80 Sales past 5Y21.90% Gross Margin61.20% 52W Low65.45% ATR0.50
Employees110 Current Ratio3.60 Sales Q/Q15.70% Oper. Margin-37.40% RSI (14)20.81 Volatility13.35% 6.40%
OptionableYes Debt/Eq0.00 EPS Q/Q-34.40% Profit Margin-37.50% Rel Volume2.29 Prev Close6.67
ShortableYes LT Debt/Eq0.00 EarningsAug 03 AMC Payout- Avg Volume556.26K Price6.32
Recom1.60 SMA20-20.06% SMA50-26.07% SMA200-21.18% Volume1,255,442 Change-5.25%
Oct-16-19Initiated Oppenheimer Outperform $6
Feb-14-19Initiated B. Riley FBR Buy $7
Nov-27-17Resumed H.C. Wainwright Buy $6 → $8
Sep-25-17Initiated Ladenburg Thalmann Buy $7
Jan-03-17Initiated Rodman & Renshaw Buy $6
Sep-15-21 04:16PM  
Sep-09-21 06:33AM  
Aug-10-21 01:22AM  
Aug-03-21 10:31PM  
Jul-27-21 03:02PM  
Jul-20-21 06:33AM  
Jul-11-21 04:11AM  
Jun-16-21 10:35AM  
Jun-11-21 01:38AM  
Jun-08-21 10:40AM  
Jun-07-21 12:19PM  
Jun-02-21 02:50AM  
May-07-21 04:30PM  
May-06-21 06:20PM  
May-04-21 06:33AM  
May-03-21 06:33AM  
Apr-29-21 06:33AM  
Apr-28-21 06:33AM  
Apr-19-21 06:33AM  
Mar-31-21 06:33AM  
Mar-28-21 04:18AM  
Mar-24-21 06:33AM  
Mar-22-21 08:42AM  
Mar-18-21 06:33AM  
Mar-16-21 06:48PM  
Mar-11-21 12:00AM  
Mar-10-21 05:35PM  
Mar-09-21 06:32AM  
Mar-08-21 09:00AM  
Mar-03-21 12:30PM  
Feb-24-21 06:30AM  
Feb-22-21 06:30AM  
Feb-20-21 02:17AM  
Feb-19-21 06:35AM  
Feb-12-21 01:13PM  
Feb-04-21 06:35AM  
Dec-22-20 12:28AM  
Dec-14-20 08:32AM  
Dec-02-20 03:49PM  
Nov-17-20 06:35AM  
Nov-09-20 06:32AM  
Nov-07-20 08:32AM  
Nov-04-20 11:32PM  
Nov-03-20 10:09AM  
Oct-28-20 06:35AM  
Oct-27-20 10:22AM  
Oct-19-20 06:32AM  
Oct-14-20 09:10AM  
Oct-08-20 06:32AM  
Oct-07-20 04:30AM  
Oct-06-20 06:35AM  
Sep-09-20 06:33AM  
Sep-01-20 04:34PM  
Aug-26-20 06:32AM  
Aug-18-20 06:32AM  
Aug-06-20 07:10PM  
Aug-05-20 09:00AM  
Jul-30-20 12:33PM  
Jul-28-20 06:32AM  
Jul-16-20 06:33AM  
Jul-14-20 06:32AM  
Jul-09-20 06:36AM  
Jul-07-20 06:34AM  
Jun-30-20 06:32AM  
Jun-17-20 06:33AM  
Jun-16-20 06:32AM  
Jun-15-20 09:42PM  
Jun-03-20 06:33AM  
Jun-01-20 06:32AM  
May-27-20 03:15PM  
May-21-20 06:32AM  
May-12-20 01:01AM  
May-11-20 05:25PM  
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The company also commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient NIAGEN; NIAGEN as an active ingredient in its consumer products under the TRU NIAGEN name; and IMMULINA, a Braun-type lipoproteins, including spirulina extracts and active compounds, which are used to support human immune function. It also offers analytical reference standards and services comprising supply of products to conduct quality control of raw materials and consumer products in dietary supplements, cosmetics, food and beverages, life sciences, and pharmaceutical industries. The company distributes TRU NIAGEN products direct to consumers through its propriety ecommerce platform, Amazon, and other internet marketplaces, as well as specialty retailers and direct healthcare practitioners in the United States. ChromaDex Corporation is headquartered in Los Angeles, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fried Robert NCEOMay 13Buy6.6510,00066,50063,001May 17 08:30 AM
BLOCK STEPHEN ADirectorMar 16Option Exercise2.6020,00052,10036,667Mar 17 06:41 PM
BLOCK STEPHEN ADirectorMar 16Sale13.1720,000263,40016,667Mar 17 06:41 PM
BLOCK STEPHEN ADirectorMar 15Option Exercise1.9232,50062,40049,167Mar 17 06:41 PM
BLOCK STEPHEN ADirectorMar 15Sale11.1532,500362,37516,667Mar 17 06:41 PM
Jaksch Frank L JrEXECUTIVE CHAIRMAN OF BOARDDec 10Option Exercise4.6241,667192,502262,168Dec 11 05:06 PM
Jaksch Frank L JrEXECUTIVE CHAIRMAN OF BOARDDec 10Sale5.1937,829196,333224,339Dec 11 05:06 PM
FARR KEVIN MCHIEF FINANCIAL OFFICERNov 06Buy4.435,00022,15041,625Nov 06 04:20 PM